research
Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure.
- Publication date
- 27 January 2019
- Publisher
- Jefferson Digital Commons